Skip to main content
Top

Hepatology International

Issue 6/2018

Content (11 Articles)

Editorial

Budd–Chiari syndrome: a focussed and collaborative approach

Amar Mukund, Shiv Kumar Sarin

Review Article

Approach and management of dysnatremias in cirrhosis

Mauro Bernardi, Giacomo Zaccherini

Original Article

Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection

Yoshihiko Ooka, Kanda Miho, Obi Shuntaro, Masato Nakamura, Sadahisa Ogasawara, Eiichiro Suzuki, Shin Yasui, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Osamu Yokosuka, Naoya Kato, Hitoshi Mochizuki, Masao Omata

Original Article

Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals

Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu

Original Article

How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?

Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Seema Alam

Original Article

Budd–Chiari syndrome has different presentations and disease severity during adolescence

Akash Shukla, Pratin Bhatt, Deepak Kumar Gupta, Tejas Modi, Jatin Patel, Amit Gupte, Megha Meshram, Shobna Bhatia

Original Article

Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis

Roman Maslennikov, Chavdar Pavlov, Vladimir Ivashkin

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.